Yi-Kai Lo, ANEUVO – ExaStim | LSI Asia '25

ANEUVO is developing a platform technology to treat chronic injuries and conditions that do not have cures through pharmaceutical approaches. The company’s lead product, ExaStim, is a noninvasive neuromodulation system that has received Breakthrough Device Designation from the U.S. FDA for treating paralysis in patients with spinal cord injury.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach